“…WW variants AA and pAA were synthesized previously . WW variants AL , LA , LL , AF , FA , FF , XA , AX , XX , XL , FL , and LF were prepared as the C-terminal acids via Fmoc-based solid-phase peptide synthesis on Fmoc-Gly-Wang resin (EMD Biosciences) as described previously. ,, Fmoc-protected amino acids with acid-labile side-chain protecting groups were purchased from Advanced ChemTech and used without further purification; we also used previously synthesized N -[(9 H -fluoren-9-ylmethoxy)- O -2-propyn-1yl- l -tyrosine. , Coupling reactions were carried out using 5 equiv of the appropriate Fmoc-protected amino acid, 5 equiv of 2-(1 H -benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 5 equiv of N -hydroxybenzotriazole hydrate, and 10 equiv of N , N -diisopropylethylamine in N -methyl-2-pyrrolidinone. Fmoc deprotection reactions were carried out using 20% piperidine in N , N -dimethylformamide.…”